Trisalus Life Sciences (TLSI)Director bought ~$25K

~$25K

Approx. value · 10K sh @ $2.46

73K

Holds after · shares reported

Traded

May 15, 2026

Filed

May 18, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 11, 2026Insider · 5 peopleInsiders: 5 sales (~$38K)
2. Mar 12, 2026Insider · 4 peopleInsiders: 4 sales (~$26K)
3. Mar 16, 2026Insider · 4 peopleInsiders: 4 sales (~$8K)
4. Mar 17, 2026InsiderCEO sold ~$61K of TLSI shares in the open market
5. Apr 1, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On April 1, 2026, TriSalus Life Sciences, Inc. (the “Company”) entered into an offer letter with Dr. Richard Marshall for the position of Chief Medical Officer.”
6. Apr 24, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 24, 2026, Jodi Devlin provided notice to TriSalus Life Sciences, Inc. (the “Company”) of her intention to retire from her role as Chief of Clinical Operations, effective October 1, 2026.”
7. May 12, 2026Company filing · Form 8-K · ResultsReported its results
8. May 15, 2026 · this disclosureInsiderDirector purchased ~$25K of TLSI shares in the open market

What came next

1. May 15, 2026Insider · 5 peopleInsiders: 5 purchases (~$1.8M), 1 sale (~$1K)
2. Aug 6, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Trisalus Life Sciences

For Trisalus Life Sciences, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TLSI page.

Other recent filings by Gary B. Gordon, Director

• SEC Form 4 at Trisalus Life Sciences (TLSI)Feb 23, 2026

The full history of Gary B. Gordon, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Trisalus Life Sciences

• SEC Form 4Oct 7, 2026
• SEC Form 4Oct 7, 2026
• SEC Form 4Oct 7, 2026
• SEC Form 4May 19, 2026
• SEC Form 4May 18, 2026
• SEC Form 4May 18, 2026

Everything OQRO holds on this company is on its TLSI page.